REGN Reports Encouraging Data on Gene Therapy for Genetic Hearing Loss (Revised)
Regeneron Pharmaceuticals, Inc. REGN announced updated data on its investigational gene therapy DB-OTO from the CHORD study. This gene therapy...
Regeneron Pharmaceuticals, Inc. REGN announced updated data on its investigational gene therapy DB-OTO from the CHORD study. This gene therapy...
Regeneron Pharmaceuticals, Inc. REGN announced updated data on its investigational gene therapy DB-OTO from the CHORD study.This gene therapy is...
Regeneron Pharmaceuticals, Inc. REGN announced updated data on its investigational gene therapy DB-OTO from the CHORD study.This gene therapy is...
Opus Genetics, Inc. released positive data from a pediatric cohort in an ongoing phase 1/2 clinical study evaluating OPGx-LCA5, an...
Prativa Baral, PhD Faculty AssociateBloomberg School of Public HealthJohns Hopkins University WHEN: Friday, February 17, 2025, from 3 to 4...
Similarly, the “smart implants” of today will become just one node in a digital ecosystem delivering post-operative care. While today’s...
(Photo : Bharath Srinivasaiah) A couple of years ago, when the world was in ruins during the COVID-19 pandemic, we...